Our study shows that MS patients, when compared to controls, have an increased expression of HDAC3 and reduced susceptibility to TSA induced apoptosis in T lymphocytes, which was associated with a lack of an increase in p53 expression in MS. This evidence concerns the gene HDAC3 and myeloid sarcoma.